安琪酵母 (600298.SH) Latest Company News

Sep 3, 2026, 09:29 UTC
Angel Yeast announced that 3.5016 million restricted shares under its 2024 restricted stock incentive plan will be unlocked and listed for trading on September 9, 2026, for 911 eligible incentive recipients.
Source:
- finance.sina.cn
Sep 1, 2026, 13:54 UTC
Angel Yeast's new subsidiary Yinong Company's Fuyou microbial inoculant project has officially commenced production, marking a step in Angel's bio-agriculture expansion.
Source:
- ce.cn
Sep 1, 2026, 08:13 UTC
Angel Yeast's wholly-owned subsidiary Kokdala Angel Yeast plans to invest 845 million yuan to build a green manufacturing project with an annual output of 20,000 tons of yeast products, with construction starting in April 2027.
Source:
- finance.sina.cn
Aug 31, 2026, 10:17 UTC
Angel Yeast's shareholders approved a proposal to build a new synthetic biology pilot-scale validation base through its enzyme preparation subsidiary.
Source:
- finance.sina.cn
Aug 22, 2026, 23:49 UTC
Gaoyi Asset increased its stake in Angel Yeast by 3 million shares in Q2 2026, with market value of 1.14 billion yuan.
Source:
- wap.eastmoney.com
Aug 14, 2026, 10:00 UTC
Angel Yeast announced its first-half 2026 results: revenue of 9.187 billion yuan, up 16.30% year-on-year; net profit attributable to shareholders of 881 million yuan, up 10.21% year-on-year; non-GAAP net profit of 794 million yuan, up 7.02% year-on-year.
Source:
- finance.sina.cn
Jul 27, 2026, 09:47 UTC
Angel Yeast's wholly-owned subsidiary Enzyme Company plans to invest 370 million yuan to build a new synthetic biology pilot verification base project.
Source:
- finance.sina.cn
- finance.sina.cn

600298.SH

Angel Yeast announced that 3.5016 million restricted shares under its 2024 restricted stock incentive plan will be unlocked and listed for trading on September 9, 2026, for 911 eligible incentive recipients.

Angel Yeast's new subsidiary Yinong Company's Fuyou microbial inoculant project has officially commenced production, marking a step in Angel's bio-agriculture expansion.

Angel Yeast's wholly-owned subsidiary Kokdala Angel Yeast plans to invest 845 million yuan to build a green manufacturing project with an annual output of 20,000 tons of yeast products, with construction starting in April 2027.

Angel Yeast's shareholders approved a proposal to build a new synthetic biology pilot-scale validation base through its enzyme preparation subsidiary.

Gaoyi Asset increased its stake in Angel Yeast by 3 million shares in Q2 2026, with market value of 1.14 billion yuan.

Angel Yeast announced its first-half 2026 results: revenue of 9.187 billion yuan, up 16.30% year-on-year; net profit attributable to shareholders of 881 million yuan, up 10.21% year-on-year; non-GAAP net profit of 794 million yuan, up 7.02% year-on-year.

Angel Yeast's wholly-owned subsidiary Enzyme Company plans to invest 370 million yuan to build a new synthetic biology pilot verification base project.